Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.

  • Authors : Maïga AI; Department of Virology, Pitié-Salpêtrière Hospital, AP-HP, EA 2387, Universite Pierre et Marie Curie, Paris, France.; Malet I

Subjects: Mutation*; DNA, Viral/DNA, Viral/DNA, Viral/*genetics ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*genetics

  • Source: Antiviral therapy [Antivir Ther] 2009; Vol. 14 (1), pp. 123-9.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.

  • Authors : Stürmer M; J.W. Goethe University Hospital, Institute for Medical Virology, Frankfurt, Germany. ; Dauer B

Subjects: Mutation*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; DNA, Viral/DNA, Viral/DNA, Viral/*blood

  • Source: Antiviral therapy [Antivir Ther] 2007; Vol. 12 (1), pp. 25-30.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy.

  • Authors : Shan M; Department of Laboratory Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.; Shen Z

Subjects: Immune Tolerance* ; Mutation*; Hepatitis B/Hepatitis B/Hepatitis B/*immunology

  • Source: Antiviral therapy [Antivir Ther] 2017; Vol. 22 (8), pp. 717-720.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Increased occurrence of mutant rtI233V of HBV in patients receiving adefovir therapy.

  • Authors : Liu Y; Institute of Infectious Diseases and Liver Failure Research Center, Beijing 302 Hospital, Beijing, China.; Xin S

Subjects: Mutation*; Adenine/Adenine/Adenine/*analogs & derivatives ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Antiviral therapy [Antivir Ther] 2016; Vol. 21 (1), pp. 9-16. Date of Electronic Publication: 2015 Jun 16.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

HBV carrying drug-resistance mutations in chronically infected treatment-naive patients.

  • Authors : Gomes-Gouvêa MS; Laboratory of Gastroenterology and Hepatology, São Paulo Institute of Tropical Medicine and Department of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil. .; Ferreira AC

Subjects: Mutation*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*genetics

  • Source: Antiviral therapy [Antivir Ther] 2015; Vol. 20 (4), pp. 387-95. Date of Electronic Publication: 2015 Jan 27.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine.

Subjects: Drug Resistance, Viral* ; Mutation*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology

  • Source: Antiviral therapy [Antivir Ther] 2015; Vol. 20 (8), pp. 779-87. Date of Electronic Publication: 2015 Jan 05.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Screening and identification of a novel adefovir dipivoxil resistance associated mutation, rtN236V, of HBV from a large cohort of HBV-infected patients.

  • Authors : Liu Y; Institute of Infectious Diseases/Liver Failure Medical Center, Beijing 302 Hospital, Beijing, China.; Liu W

Subjects: Mutation*; Adenine/Adenine/Adenine/*analogs & derivatives ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology

  • Source: Antiviral therapy [Antivir Ther] 2014; Vol. 19 (6), pp. 551-8. Date of Electronic Publication: 2014 Apr 08.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Evolution of hepatitis B virus mutation during entecavir rescue therapy in patients with antiviral resistance to lamivudine and adefovir.

  • Authors : Choe WH; Department of Internal Medicine, Konkuk University School of Medicine, Konkuk University Hospital, Seoul, South Korea.; Hong SP

Subjects: Mutation*; Adenine/Adenine/Adenine/*analogs & derivatives ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage

  • Source: Antiviral therapy [Antivir Ther] 2009; Vol. 14 (7), pp. 985-93.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations.

  • Authors : Wang XY; Peking University People's Hospital, Peking University Hepatology Institute, Beijing, China.; Wei ZM

Subjects: Mutation*; Adenine/Adenine/Adenine/*analogs & derivatives ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology

  • Source: Antiviral therapy [Antivir Ther] 2012; Vol. 17 (5), pp. 793-803. Date of Electronic Publication: 2012 Jun 06.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.

  • Authors : Ueda Y; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. ; Marusawa H

Subjects: Living Donors* ; Mutation*; Hepatitis B Antibodies/Hepatitis B Antibodies/Hepatitis B Antibodies/*immunology

  • Source: Antiviral therapy [Antivir Ther] 2011; Vol. 16 (4), pp. 479-87.Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  16 results for ""DNA, Viral""